MedTrace Logo

Longitudinal Follow-Up of Patients Treated With Hypofractionated Stereotactic Photon Radiotherapy Due to Uveal Melanoma

NCT06280040 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2024-03-06

No results posted yet for this study

Summary

The purpose of this study is to evaluate the incidence and severity of retinopathy and opticopathy one year after treatment with hypofractionated stereotactic photon radiotherapy due to uveal melanoma. Patients will be imaged before radiation, as well as 3, 6, 9 and 12 months after radiation using sonography funds photography, optical coherence tomography angiography, oximeter and microperimetry.

Conditions

Interventions

DIAGNOSTIC_TEST

Clinical examination and multimodal ocular imaging

Imaging consists of sonography, fundus photography, oximeter, optical coherence tomography angiography, and Microperimetry.

Sponsors & Collaborators

  • Medical University of Vienna

    lead OTHER

Principal Investigators

  • Reinhard Told, MD, PhD · Department for Ophthalmology and Optometry, Medical University of Vienna

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-11-23
Primary Completion
2025-06-30
Completion
2025-06-30

Countries

  • Austria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06280040 on ClinicalTrials.gov